You are here: Industry Insights > consumer health

News List

Why GlaxoSmithKline and Pfizer are spinning out their consumer health business firstwordpharma
January 21, 2019
GlaxoSmithKline and Pfizer are among the drugmakers that are seeking to offload non-core units in an effort to increase focus, Business Insider reported Friday.
Why GlaxoSmithKline and Pfizer are spinning out their consumer health business firstwordpharma
January 21, 2019
GlaxoSmithKline and Pfizer are among the drugmakers that are seeking to offload non-core units in an effort to increase focus, Business Insider reported Friday.
Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho: report fiercepharma
January 03, 2019
Amid an industrywide shift away from the sector, Bristol-Myers Squibb is close to becoming the latest Big Pharma to exit consumer health. And word is Japan’s Taisho will be the one to help the company do it.
GSK, Pfizer go for radical makeovers with giant consumer combo destined for spinoff fiercepharma
December 25, 2018
Turns out, after GlaxoSmithKline walked away from a chance to scoop up Pfizer’s consumer health business in March, it got another opportunity to team up on a deal.
Will pharma's exodus from consumer health continue into 2019? It sure looks that way fiercepharma
December 24, 2018
The year 2018 might be remembered by the pharma world for a deluge of consumer health castoffs. And one doesn’t really need a crystal ball to see the trend continue into the near future as drugmakers turn
Bristol-Myers Squibb hands Upsa consumer biz to Taisho for $1.6B fiercepharma
December 20, 2018
When it rains, it pours. Just as Pfizer and GlaxoSmithKline teamed up on an industry-leading consumer health joint venture, Bristol-Myers Squibb struck its own deal in the sector.
Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho: report fiercepharma
December 19, 2018
Amid an industrywide shift away from the sector, Bristol-Myers Squibb is close to becoming the latest Big Pharma to exit consumer health. And word is Japan’s Taisho will be the one to help the company do it.
GSK considers splitting up pharmatimes
July 24, 2018
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
GSK to buy-out Novartis’ stake in consumer health JV pharmatimes
July 20, 2018
GlaxoSmithKline is buying Novartis’ stake in the firms’ consumer healthcare unit, the announcement coming just days after the drug giant said it would not pursue acquisition of Pfizer’s consumer healthcare business.
Merck sells consumer healthcare unit to P&G pharmatimes
July 16, 2018
Germany’s Merck is selling its consumer health unit to Procter & Gamble for around for 3.4 billion Euros.

Previous page 1 2 Next page